4.7 Article

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease

Related references

Note: Only part of the references are listed.
Article Psychology, Multidisciplinary

Processing speed and working memory are predicted by components of successful aging: a HUNT study

Ingunn Bosnes et al.

Summary: This study explored the relationship between cognitive heterogeneity and successful aging or usual aging. The results showed that absence of disease was associated with processing speed and working memory, while other cognitive domains were not related to successful aging components.

BMC PSYCHOLOGY (2022)

Article Multidisciplinary Sciences

Short-term memory advantage for brief durations in human APOE ε4 carriers

Nahid Zokaei et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease

Maria Fe Lanfranco et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Psychology, Clinical

Effects of APOE on Cognitive Aging in Community-Dwelling Older Adults

Emilie T. Reas et al.

NEUROPSYCHOLOGY (2019)

Article Gerontology

Trajectories of Normal Cognitive Aging

Timothy A. Salthouse

PSYCHOLOGY AND AGING (2019)

Review Neurosciences

Risk factors for Alzheimer's disease

Richard A. Armstrong

FOLIA NEUROPATHOLOGICA (2019)

Article Clinical Neurology

The neuropsychology of normal aging and preclinical Alzheimer's disease

Richard J. Caselli et al.

ALZHEIMERS & DEMENTIA (2014)

Article Geriatrics & Gerontology

Cognitive and neural signatures of the APOE E4 allele in mid-aged adults

Simon Evans et al.

NEUROBIOLOGY OF AGING (2014)

Article Clinical Neurology

APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory

Geoffrey A. Kerchner et al.

NEUROLOGY (2014)

Article Clinical Neurology

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease

Marwan N. Sabbagh et al.

BMC NEUROLOGY (2013)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Chia-Chan Liu et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Medicine, General & Internal

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Geriatrics & Gerontology

The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis

Nick M. Wisdom et al.

NEUROBIOLOGY OF AGING (2011)

Article Neurosciences

Apolipoprotein ε4 and neuropsychological performance in Alzheimer's disease and vascular dementia

Bernadette McGuinness et al.

NEUROSCIENCE LETTERS (2010)

Article Neurosciences

CSF Biomarkers in Alzheimer's Disease and Controls: Associations with APOE Genotype are Modified by Age

Maartje I. Kester et al.

JOURNAL OF ALZHEIMERS DISEASE (2009)

Review Behavioral Sciences

Cognitive reserve

Yaakov Stern

NEUROPSYCHOLOGIA (2009)

Article Neurosciences

Decreased Cognition in Children with Risk Factors for Alzheimer's Disease

Cinnamon S. Bloss et al.

BIOLOGICAL PSYCHIATRY (2008)

Article Gerontology

Apolipoprotein E and cognitive performance:: A meta-analysis

BJ Small et al.

PSYCHOLOGY AND AGING (2004)

Article Clinical Neurology

Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred

P Pastor et al.

ANNALS OF NEUROLOGY (2003)

Article Neurosciences

Influence of the apolipoprotein E ε4 allele on human embryonic development

H Zetterberg et al.

NEUROSCIENCE LETTERS (2002)